Testing effectiveness (Phase 2)WithdrawnNCT04354727
What this trial is testing
APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy
Who this might be right for
Myelofibrosis
Ascentage Pharma Group Inc.
Showing 20 of 0 results